Burden of Respiratory Syncytial Virus-Associated Acute Respiratory Infections During Pregnancy
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
BACKGROUND: With the licensure of maternal respiratory syncytial virus (RSV) vaccines in Europe and the United States, data are needed to better characterize the burden of RSV-associated acute respiratory infections (ARI) in pregnancy. The current study aimed to determine among pregnant individuals the proportion of ARI testing positive for RSV and the RSV incidence rate, RSV-associated hospitalizations, deaths, and perinatal outcomes.
METHODS: We conducted a systematic review, following PRISMA 2020 guidelines, using 5 databases (Medline, Embase, Global Health, Web of Science, and Global Index Medicus), and including additional unpublished data. Pregnant individuals with ARI who had respiratory samples tested for RSV were included. We used a random-effects meta-analysis to generate overall proportions and rate estimates across studies.
RESULTS: Eleven studies with pregnant individuals recruited between 2010 and 2022 were identified, most of which recruited pregnant individuals in community, inpatient and outpatient settings. Among 8126 pregnant individuals, the proportion with ARI that tested positive for RSV ranged from 0.9% to 10.7%, with a meta-estimate of 3.4% (95% confidence interval [CI], 1.9%-54%). The pooled incidence rate of RSV among pregnant individuals was 26.0 (95% CI, 15.8-36.2) per 1000 person-years. RSV hospitalization rates reported in 2 studies were 2.4 and 3.0 per 1000 person-years. In 5 studies that ascertained RSV-associated deaths among 4708 pregnant individuals, no deaths were reported. Three studies comparing RSV-positive and RSV-negative pregnant individuals found no difference in the odds of miscarriage, stillbirth, low birth weight, and small size for gestational age. RSV-positive pregnant individuals had higher odds of preterm delivery (odds ratio, 3.6 [95% CI, 1.3-10.3]).
CONCLUSIONS: Data on RSV-associated hospitalization rates are limited, but available estimates are lower than those reported in older adults and young children. As countries debate whether to include RSV vaccines in maternal vaccination programs, which are primarily intended to protect infants, this information could be useful in shaping vaccine policy decisions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:229 |
|---|---|
| Enthalten in: |
The Journal of infectious diseases - 229(2024), Supplement_1 vom: 01. März, Seite S51-S60 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kenmoe, Sebastien [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Disease burden |
|---|
| Anmerkungen: |
Date Completed 04.03.2024 Date Revised 08.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/infdis/jiad449 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363174583 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363174583 | ||
| 003 | DE-627 | ||
| 005 | 20240309231933.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/infdis/jiad449 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1321.xml |
| 035 | |a (DE-627)NLM363174583 | ||
| 035 | |a (NLM)37824420 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kenmoe, Sebastien |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Burden of Respiratory Syncytial Virus-Associated Acute Respiratory Infections During Pregnancy |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.03.2024 | ||
| 500 | |a Date Revised 08.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a BACKGROUND: With the licensure of maternal respiratory syncytial virus (RSV) vaccines in Europe and the United States, data are needed to better characterize the burden of RSV-associated acute respiratory infections (ARI) in pregnancy. The current study aimed to determine among pregnant individuals the proportion of ARI testing positive for RSV and the RSV incidence rate, RSV-associated hospitalizations, deaths, and perinatal outcomes | ||
| 520 | |a METHODS: We conducted a systematic review, following PRISMA 2020 guidelines, using 5 databases (Medline, Embase, Global Health, Web of Science, and Global Index Medicus), and including additional unpublished data. Pregnant individuals with ARI who had respiratory samples tested for RSV were included. We used a random-effects meta-analysis to generate overall proportions and rate estimates across studies | ||
| 520 | |a RESULTS: Eleven studies with pregnant individuals recruited between 2010 and 2022 were identified, most of which recruited pregnant individuals in community, inpatient and outpatient settings. Among 8126 pregnant individuals, the proportion with ARI that tested positive for RSV ranged from 0.9% to 10.7%, with a meta-estimate of 3.4% (95% confidence interval [CI], 1.9%-54%). The pooled incidence rate of RSV among pregnant individuals was 26.0 (95% CI, 15.8-36.2) per 1000 person-years. RSV hospitalization rates reported in 2 studies were 2.4 and 3.0 per 1000 person-years. In 5 studies that ascertained RSV-associated deaths among 4708 pregnant individuals, no deaths were reported. Three studies comparing RSV-positive and RSV-negative pregnant individuals found no difference in the odds of miscarriage, stillbirth, low birth weight, and small size for gestational age. RSV-positive pregnant individuals had higher odds of preterm delivery (odds ratio, 3.6 [95% CI, 1.3-10.3]) | ||
| 520 | |a CONCLUSIONS: Data on RSV-associated hospitalization rates are limited, but available estimates are lower than those reported in older adults and young children. As countries debate whether to include RSV vaccines in maternal vaccination programs, which are primarily intended to protect infants, this information could be useful in shaping vaccine policy decisions | ||
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a disease burden | |
| 650 | 4 | |a pregnancy | |
| 650 | 4 | |a respiratory syncytial virus | |
| 700 | 1 | |a Chu, Helen Y |e verfasserin |4 aut | |
| 700 | 1 | |a Dawood, Fatimah S |e verfasserin |4 aut | |
| 700 | 1 | |a Milucky, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Kittikraisak, Wanitchaya |e verfasserin |4 aut | |
| 700 | 1 | |a Matthewson, Hamish |e verfasserin |4 aut | |
| 700 | 1 | |a Kulkarni, Durga |e verfasserin |4 aut | |
| 700 | 1 | |a Suntarattiwong, Piyarat |e verfasserin |4 aut | |
| 700 | 1 | |a Frivold, Collrane |e verfasserin |4 aut | |
| 700 | 1 | |a Mohanty, Sarita |e verfasserin |4 aut | |
| 700 | 1 | |a Havers, Fiona |e verfasserin |4 aut | |
| 700 | 1 | |a Li, You |e verfasserin |4 aut | |
| 700 | 1 | |a Nair, Harish |e verfasserin |4 aut | |
| 700 | 0 | |a PROMISE Investigators |e verfasserin |4 aut | |
| 700 | 1 | |a Aerssens, Jeroen |e investigator |4 oth | |
| 700 | 1 | |a Callendret, Benoit |e investigator |4 oth | |
| 700 | 1 | |a Ispas, Gabriela |e investigator |4 oth | |
| 700 | 1 | |a Ahani, Bahar |e investigator |4 oth | |
| 700 | 1 | |a Atwell, Jessica |e investigator |4 oth | |
| 700 | 1 | |a Begier, Elizabeth |e investigator |4 oth | |
| 700 | 1 | |a Turiga, Monica |e investigator |4 oth | |
| 700 | 1 | |a Htar, Tin Tin |e investigator |4 oth | |
| 700 | 1 | |a Bangert, Mathieu |e investigator |4 oth | |
| 700 | 1 | |a Kramer, Rolf |e investigator |4 oth | |
| 700 | 1 | |a Vernhes, Charlotte |e investigator |4 oth | |
| 700 | 1 | |a Beutels, Philippe |e investigator |4 oth | |
| 700 | 1 | |a Bont, Louis |e investigator |4 oth | |
| 700 | 1 | |a Campbell, Harry |e investigator |4 oth | |
| 700 | 1 | |a Nair, Harish |e investigator |4 oth | |
| 700 | 1 | |a Li, You |e investigator |4 oth | |
| 700 | 1 | |a Kenmoe, Sebastien |e investigator |4 oth | |
| 700 | 1 | |a Osei-Yeboah, Richard |e investigator |4 oth | |
| 700 | 1 | |a Wang, Xin |e investigator |4 oth | |
| 700 | 1 | |a Cohen, Rachel |e investigator |4 oth | |
| 700 | 1 | |a Dos Santos, Gael |e investigator |4 oth | |
| 700 | 1 | |a Joosten, Philip |e investigator |4 oth | |
| 700 | 1 | |a Last, Theo |e investigator |4 oth | |
| 700 | 1 | |a Kumar, Veena |e investigator |4 oth | |
| 700 | 1 | |a Machin, Nuria |e investigator |4 oth | |
| 700 | 1 | |a Nohynek, Hanna |e investigator |4 oth | |
| 700 | 1 | |a Openshaw, Peter |e investigator |4 oth | |
| 700 | 1 | |a Paget, John |e investigator |4 oth | |
| 700 | 1 | |a Pollard, Andrew |e investigator |4 oth | |
| 700 | 1 | |a Teirlinck, Anne |e investigator |4 oth | |
| 700 | 1 | |a Urchueguía-Fornes, Arantxa |e investigator |4 oth | |
| 700 | 1 | |a Mira-Iglesias, Ainara |e investigator |4 oth | |
| 700 | 1 | |a Orrico-Sánchez, Alejandro |e investigator |4 oth | |
| 700 | 1 | |a Díez-Domingo, Javier |e investigator |4 oth | |
| 700 | 1 | |a Klint, Johannesen Caroline |e investigator |4 oth | |
| 700 | 1 | |a Miller, Mark |e investigator |4 oth | |
| 700 | 1 | |a Mikolajczyk, Rafael |e investigator |4 oth | |
| 700 | 1 | |a Heikkinen, Terho |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 229(2024), Supplement_1 vom: 01. März, Seite S51-S60 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
| 773 | 1 | 8 | |g volume:229 |g year:2024 |g number:Supplement_1 |g day:01 |g month:03 |g pages:S51-S60 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiad449 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 229 |j 2024 |e Supplement_1 |b 01 |c 03 |h S51-S60 | ||